KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Enterprise Value (2016 - 2025)

Teladoc Health's Enterprise Value history spans 13 years, with the latest figure at -$781.1 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 39.84% year-over-year to -$781.1 million; the TTM value through Dec 2025 reached -$781.1 million, up 39.84%, while the annual FY2025 figure was -$781.1 million, 39.84% up from the prior year.
  • Enterprise Value for Q4 2025 was -$781.1 million at Teladoc Health, down from -$726.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$679.6 million in Q2 2025 and bottomed at -$1.3 billion in Q4 2024.
  • The 5-year median for Enterprise Value is -$897.8 million (2021), against an average of -$947.8 million.
  • The largest annual shift saw Enterprise Value plummeted 41.48% in 2021 before it surged 41.61% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$896.0 million in 2021, then dropped by 2.47% to -$918.2 million in 2022, then dropped by 22.38% to -$1.1 billion in 2023, then decreased by 15.54% to -$1.3 billion in 2024, then soared by 39.84% to -$781.1 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Enterprise Value are -$781.1 million (Q4 2025), -$726.2 million (Q3 2025), and -$679.6 million (Q2 2025).